Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy based on SRC and aurora kinase inhibition for the treatment of cancer

Combination therapy based on SRC and aurora kinase inhibition for the treatment of cancer

US Patent 9101631 · Granted Aug 11, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor2025
Methods for diagnosis and treatment of patients having solid tumors2023
Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor2022
Systems and methods for treating patients having a genetic predisposition to dev2020
Systems and methods for treating patients having a genetic predisposition to dev2020
EGFR/NEDD9/TGF-β interactome and methods of use thereof for the identification o2019
EGFR/NEDD9/TGF-β interactome and methods of use thereof for the identification o2019
EGFR/NEDD9/TGF-β interactome and methods of use thereof for the identification o2019
EGFR/NEDD9/TGF-β interactome and methods of use thereof for the identification o2019
Non-invasive monitoring cancer using integrated microfluidic profiling of circul2019
C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II i2019
C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II i2019